Ipsen SA

IPN.PA · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

266 EUR (≈ 304.13 USD)

Margin of Safety

+40.6 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Ipsen SA is a French specialty pharmaceutical company that generates revenues primarily from patent-protected niche therapeutics in the fields of oncology, neurology/neurodegeneration, and rare diseases, relying on a model combining internal research, licensing, and selective pipeline expansion.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.